11:27 am GlaxoSmithKline receives positive CHMP opinion for Mekinis in metastatic melanoma with a BRAF V600 mutation – HedgeChatter

11:27 am GlaxoSmithKline receives positive CHMP opinion for Mekinis in metastatic melanoma with a BRAF V600 mutation

28 Apr

11:27 am GlaxoSmithKline receives positive CHMP opinion for Mekinis in metastatic melanoma with a BRAF V600 mutation

Bystocknews GSK, stock Comments Off

View todays social media effects on GSK

View the latest stocks trending across Twitter. Click to view dashboard

See who GlaxoSmithKline is hiring next, click here to view

Author